Brett Sandercock - 10 May 2023 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Issuer symbol
RMD
Transactions as of
10 May 2023
Net transactions value
-$2,931,395
Form type
4
Filing time
12 May 2023, 19:30:54 UTC
Previous filing
10 May 2023
Next filing
18 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale $2,931,395 -12,574 -12% $233.13 90,942 10 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted during an open trading window.